Open AccessAllicin as add-on therapy for Helicobacter pylori infection: A systematic review and meta-analysis
Author(s) -
Xiaobei Si,
Xumin Zhang,
Shuai Wang,
Yu Lan,
Shuo Zhang,
Linyu Huo
Publication year - 2019
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v25.i39.6025
Subject(s) - allicin , medicine , randomized controlled trial , meta analysis , helicobacter pylori , publication bias , cochrane library , odds ratio , confidence interval , medline , biology , biochemistry
Allicin (2-propene-1-sulfinothioic acid S-2-propenyl ester, diallyl thiosulfinate) extracted from garlic, has proven activity against Helicobacter pylori ( H. Pylori ) infection. In recent years, clinical trials have explored its utility as an add-on therapy with variable outcomes reported.